TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles November 4, 1983